Roivant Sciences Ltd. SEC filings ROIV

Roivant Sciences Ltd. has 995 filings in SEC EDGAR's recent list, going back to Mar 16, 2015. Its latest annual report, Form ARS, was filed on Jul 29, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (regulation fd disclosure). The company's fiscal year ends on March 31.

Roivant Sciences Ltd. SEC filings
Form Description Filed Period
144 Notice of proposed sale Nov 3, 2026 —
4 Insider transaction Oct 30, 2026 Oct 28, 2026
144 Notice of proposed sale Oct 28, 2026 —
4 Insider transaction Oct 27, 2026 Oct 23, 2026
4 Insider transaction Oct 27, 2026 Oct 23, 2026
4 Insider transaction Oct 27, 2026 Oct 23, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 27, 2026 —
4 Insider transaction Oct 22, 2026 Oct 20, 2026
8-K Current report
Regulation FD disclosure
Oct 21, 2026 Oct 21, 2026
4 Insider transaction Oct 20, 2026 Oct 16, 2026
4 Insider transaction Oct 20, 2026 Oct 16, 2026
144 Notice of proposed sale Oct 20, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Oct 5, 2026 —
4 Insider transaction Oct 5, 2026 Oct 1, 2026
4 Insider transaction Oct 5, 2026 Oct 1, 2026
4 Insider transaction Oct 2, 2026 Sep 30, 2026
4 Insider transaction Oct 2, 2026 Sep 30, 2026
4 Insider transaction Oct 2, 2026 Sep 30, 2026
4 Insider transaction Oct 2, 2026 Sep 30, 2026
144 Notice of proposed sale Sep 30, 2026 —
4 Insider transaction Sep 22, 2026 Sep 20, 2026
4 Insider transaction Sep 22, 2026 Sep 20, 2026
4 Insider transaction Sep 18, 2026 Sep 16, 2026
4 Insider transaction Sep 18, 2026 Sep 16, 2026
4 Insider transaction Sep 18, 2026 Sep 16, 2026
4 Insider transaction Sep 18, 2026 Sep 16, 2026
4 Insider transaction Sep 18, 2026 Sep 16, 2026
4 Insider transaction Sep 18, 2026 Sep 16, 2026
8-K Current report
Shareholder vote results
Sep 18, 2026 Sep 16, 2026
4 Insider transaction Sep 17, 2026 Sep 15, 2026
4 Insider transaction Sep 17, 2026 Sep 15, 2026
144 Notice of proposed sale Sep 15, 2026 —
144 Notice of proposed sale Sep 15, 2026 —
4 Insider transaction Sep 14, 2026 Sep 10, 2026
4 Insider transaction Sep 14, 2026 Sep 10, 2026
4 Insider transaction Sep 14, 2026 Sep 10, 2026
4 Insider transaction Sep 14, 2026 Sep 10, 2026
4 Insider transaction Sep 14, 2026 Sep 10, 2026
4 Insider transaction Sep 10, 2026 Sep 8, 2026
144 Notice of proposed sale Sep 8, 2026 —
8-K Current report
Regulation FD disclosure
Sep 8, 2026 Sep 8, 2026
4 Insider transaction Sep 1, 2026 Aug 28, 2026
144 Notice of proposed sale Aug 28, 2026 —
8-K Current report
Other events
Aug 28, 2026 Aug 28, 2026
8-K Current report
Regulation FD disclosure
Aug 27, 2026 Aug 27, 2026
4 Insider transaction Aug 24, 2026 Aug 20, 2026
4 Insider transaction Aug 24, 2026 Aug 20, 2026
4 Insider transaction Aug 21, 2026 Aug 19, 2026
144 Notice of proposed sale Aug 21, 2026 —
144 Notice of proposed sale Aug 20, 2026 —
144 Notice of proposed sale Aug 19, 2026 —
4 Insider transaction Aug 18, 2026 Aug 14, 2026
144 Notice of proposed sale Aug 18, 2026 —
144 Notice of proposed sale Aug 17, 2026 —
144 Notice of proposed sale Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2026 —
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
4 Insider transaction Jul 29, 2026 Jul 27, 2026
ARS Annual report to shareholders Jul 29, 2026 Mar 31, 2026
DEFA14A Additional proxy material Jul 29, 2026 —
DEF 14A Proxy statement Jul 29, 2026 Sep 16, 2026
144 Notice of proposed sale Jul 27, 2026 —
4 Insider transaction Jul 21, 2026 Jul 17, 2026
4 Insider transaction Jul 21, 2026 Jul 17, 2026
4 Insider transaction Jul 21, 2026 Jul 17, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jul 1, 2026 Jun 29, 2026
4 Insider transaction Jun 30, 2026 Jun 26, 2026
4 Insider transaction Jun 30, 2026 Jun 26, 2026
4 Insider transaction Jun 30, 2026 Jun 26, 2026
144 Notice of proposed sale Jun 30, 2026 —
144 Notice of proposed sale Jun 30, 2026 —
4 Insider transaction Jun 29, 2026 Jun 25, 2026
144 Notice of proposed sale Jun 29, 2026 —
4 Insider transaction Jun 26, 2026 Jun 24, 2026
144 Notice of proposed sale Jun 26, 2026 —
144 Notice of proposed sale Jun 25, 2026 —
144 Notice of proposed sale Jun 24, 2026 —
4 Insider transaction Jun 23, 2026 Jun 20, 2026
4 Insider transaction Jun 23, 2026 Jun 20, 2026
4 Insider transaction May 22, 2026 May 20, 2026
4 Insider transaction May 22, 2026 May 20, 2026
144 Notice of proposed sale May 22, 2026 —
S-8 Employee stock plan registration May 20, 2026 —
10-K Annual report May 20, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 20, 2026 May 20, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 12, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 6, 2026 —
4 Insider transaction Apr 22, 2026 Apr 20, 2026
4 Insider transaction Apr 22, 2026 Apr 20, 2026
4 Insider transaction Apr 22, 2026 Apr 20, 2026
4 Insider transaction Apr 21, 2026 Apr 17, 2026
4 Insider transaction Apr 21, 2026 Apr 17, 2026
4 Insider transaction Apr 21, 2026 Apr 17, 2026
4 Insider transaction Apr 20, 2026 Apr 16, 2026
144 Notice of proposed sale Apr 20, 2026 —
144/A Filing Apr 16, 2026 —
144 Notice of proposed sale Apr 16, 2026 —
4 Insider transaction Apr 10, 2026 Apr 8, 2026
144 Notice of proposed sale Apr 8, 2026 —
4 Insider transaction Apr 2, 2026 Mar 31, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Apr 2, 2026 Apr 2, 2026
4 Insider transaction Apr 1, 2026 Mar 30, 2026
4 Insider transaction Apr 1, 2026 Mar 30, 2026
4 Insider transaction Mar 30, 2026 Mar 26, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
144 Notice of proposed sale Mar 26, 2026 —
4 Insider transaction Mar 24, 2026 Mar 20, 2026
4 Insider transaction Mar 24, 2026 Mar 20, 2026
8-K/A Amended current report
Material agreement
Mar 23, 2026 Mar 3, 2026
4 Insider transaction Mar 19, 2026 Mar 17, 2026
4 Insider transaction Mar 18, 2026 Mar 16, 2026
144 Notice of proposed sale Mar 17, 2026 —
144 Notice of proposed sale Mar 16, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 6, 2026 —
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Mar 3, 2026 Mar 3, 2026
8-K Current report
Regulation FD disclosure
Mar 3, 2026 Mar 3, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
4 Insider transaction Feb 23, 2026 Feb 19, 2026
144 Notice of proposed sale Feb 20, 2026 —
144 Notice of proposed sale Feb 19, 2026 —
4 Insider transaction Feb 18, 2026 Feb 13, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
4 Insider transaction Feb 13, 2026 Feb 11, 2026
4 Insider transaction Feb 13, 2026 Feb 11, 2026
4 Insider transaction Feb 13, 2026 Feb 11, 2026
144 Notice of proposed sale Feb 13, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
4 Insider transaction Feb 11, 2026 Feb 9, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 11, 2026 —
144 Notice of proposed sale Feb 9, 2026 —
10-Q Quarterly report Feb 6, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 6, 2026 Feb 6, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 5, 2026 —
4 Insider transaction Jan 22, 2026 Jan 20, 2026
4 Insider transaction Jan 22, 2026 Jan 20, 2026
4 Insider transaction Jan 22, 2026 Jan 20, 2026
4 Insider transaction Jan 14, 2026 Jan 12, 2026
144 Notice of proposed sale Jan 12, 2026 —
4 Insider transaction Dec 31, 2025 Dec 29, 2025
144 Notice of proposed sale Dec 31, 2025 —
4 Insider transaction Dec 29, 2025 Dec 23, 2025
4 Insider transaction Dec 29, 2025 Dec 23, 2025
4 Insider transaction Dec 29, 2025 Dec 23, 2025
144 Notice of proposed sale Dec 29, 2025 —
144 Notice of proposed sale Dec 29, 2025 —
144 Notice of proposed sale Dec 29, 2025 —
4 Insider transaction Dec 23, 2025 Dec 20, 2025
144 Notice of proposed sale Dec 23, 2025 —
144 Notice of proposed sale Dec 23, 2025 —
144 Notice of proposed sale Dec 23, 2025 —
4 Insider transaction Dec 19, 2025 Dec 17, 2025
4 Insider transaction Dec 18, 2025 Dec 16, 2025
4 Insider transaction Dec 18, 2025 Dec 16, 2025
4 Insider transaction Dec 18, 2025 Dec 16, 2025
4 Insider transaction Dec 17, 2025 Dec 15, 2025
144 Notice of proposed sale Dec 17, 2025 —
4 Insider transaction Dec 15, 2025 Dec 11, 2025
144/A Filing Dec 15, 2025 —
144 Notice of proposed sale Dec 15, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Dec 12, 2025 —
4 Insider transaction Dec 12, 2025 Dec 12, 2025
4 Insider transaction Dec 11, 2025 Dec 9, 2025
8-K Current report
Regulation FD disclosure
Dec 11, 2025 Dec 11, 2025
144 Notice of proposed sale Dec 9, 2025 —
4 Insider transaction Nov 24, 2025 Nov 20, 2025
4 Insider transaction Nov 24, 2025 Nov 20, 2025
4 Insider transaction Nov 21, 2025 Nov 19, 2025
4 Insider transaction Nov 21, 2025 Nov 19, 2025
4 Insider transaction Nov 21, 2025 Nov 19, 2025
4 Insider transaction Nov 17, 2025 Nov 13, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
10-Q Quarterly report Nov 10, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 10, 2025 Nov 10, 2025
4 Insider transaction Nov 7, 2025 Nov 7, 2025
144 Notice of proposed sale Nov 7, 2025 —
4 Insider transaction Oct 22, 2025 Oct 20, 2025
4 Insider transaction Oct 22, 2025 Oct 20, 2025
4 Insider transaction Oct 22, 2025 Oct 20, 2025
4 Insider transaction Oct 17, 2025 Oct 15, 2025
144 Notice of proposed sale Oct 17, 2025 —
144 Notice of proposed sale Oct 16, 2025 —
144 Notice of proposed sale Oct 15, 2025 —
4 Insider transaction Oct 14, 2025 Oct 9, 2025
144 Notice of proposed sale Oct 14, 2025 —
144 Notice of proposed sale Oct 9, 2025 —
4 Insider transaction Oct 8, 2025 Oct 6, 2025
144 Notice of proposed sale Oct 8, 2025 —
144 Notice of proposed sale Oct 7, 2025 —
144 Notice of proposed sale Oct 6, 2025 —
S-3ASR Automatic shelf registration Oct 3, 2025 —
4 Insider transaction Sep 30, 2025 Sep 28, 2025
4 Insider transaction Sep 23, 2025 Sep 20, 2025
4 Insider transaction Sep 23, 2025 Sep 19, 2025

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ROIV (Nasdaq)
Fiscal year ends
March 31
Incorporated in
Bermuda
Headquarters
London
SEC filer status
Large accelerated filer
SEC CIK
1635088

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.